gaboxadol has been researched along with Ischemic Attack, Transient in 1 studies
gaboxadol: GABA agonist; inhibitor of GABA uptake systems; structure
Ischemic Attack, Transient: Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nielsen, EO | 1 |
| Aarslew-Jensen, M | 1 |
| Diemer, NH | 1 |
| Krogsgaard-Larsen, P | 1 |
| Schousboe, A | 1 |
1 other study available for gaboxadol and Ischemic Attack, Transient
| Article | Year |
|---|---|
Baclofen-induced, calcium-dependent stimulation of in vivo release of D-[3H]aspartate from rat hippocampus monitored by intracerebral microdialysis.
Topics: Animals; Aspartic Acid; Baclofen; Calcium; GABA Antagonists; Hippocampus; Ischemic Attack, Transient | 1989 |